COPD treatment may increase risk of TB
Fluticasone/salmeterol treatment for chronic obstructive pulmonary disease (COPD) may be associated with a higher risk of active tuberculosis (TB), according to a study published in BMC Infectious Diseases.
Fluticasone/salmeterol treatment for chronic obstructive pulmonary disease (COPD) may be associated with a higher risk of active tuberculosis (TB), according to a study published in BMC Infectious Diseases.
